Nurix Therapeutics IncNASDAQ:NRIX
- LAST PRICE20.9100
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots19.6100/ 1
- Ask / Lots22.8800/ 1
- Open / Previous Close0.0000 / 20.9100
- Day Range---
- 52 Week Range
- Volume---
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | NRIX |
|---|---|---|
| 09:32 ET | 34216 | 21.29 |
| 09:34 ET | 4433 | 21.24 |
| 09:36 ET | 4123 | 21.3 |
| 09:38 ET | 11307 | 21.7599 |
| 09:39 ET | 24608 | 21.84 |
| 09:41 ET | 4500 | 21.87 |
| 09:43 ET | 11776 | 21.48 |
| 09:45 ET | 16275 | 20.7935 |
| 09:48 ET | 3428 | 21.37 |
| 09:50 ET | 4891 | 21.44 |
| 09:52 ET | 200 | 21.44 |
| 09:54 ET | 2401 | 21.31 |
| 09:56 ET | 300 | 21.31 |
| 09:57 ET | 5404 | 21.425 |
| 09:59 ET | 4138 | 21.67 |
| 10:01 ET | 7981 | 21.5 |
| 10:03 ET | 17659 | 21.44 |
| 10:06 ET | 2200 | 21.45 |
| 10:08 ET | 12855 | 21.44 |
| 10:10 ET | 922 | 21.405 |
| 10:12 ET | 8479 | 21.31 |
| 10:14 ET | 4487 | 21.34 |
| 10:15 ET | 4100 | 21.31 |
| 10:17 ET | 100 | 21.36 |
| 10:19 ET | 10687 | 21.52 |
| 10:21 ET | 13754 | 21.5 |
| 10:24 ET | 13003 | 21.515 |
| 10:26 ET | 500 | 21.55 |
| 10:28 ET | 7665 | 21.62 |
| 10:30 ET | 1388 | 21.803 |
| 10:32 ET | 2822 | 21.693 |
| 10:33 ET | 2000 | 21.485 |
| 10:35 ET | 500 | 21.515 |
| 10:37 ET | 2618 | 21.5 |
| 10:39 ET | 2200 | 21.47 |
| 10:42 ET | 2600 | 21.47 |
| 10:44 ET | 7089 | 21.25 |
| 10:46 ET | 7932 | 21.055 |
| 10:48 ET | 1087 | 21.03 |
| 10:50 ET | 718 | 20.98 |
| 10:51 ET | 4385 | 20.92 |
| 10:53 ET | 900 | 20.82 |
| 10:55 ET | 1027 | 20.86 |
| 10:57 ET | 600 | 20.88 |
| 11:00 ET | 2772 | 20.91 |
| 11:02 ET | 600 | 20.92 |
| 11:04 ET | 1578 | 20.95 |
| 11:06 ET | 1222 | 20.9299 |
| 11:08 ET | 627 | 20.9 |
| 11:09 ET | 1200 | 20.83 |
| 11:11 ET | 400 | 20.8 |
| 11:13 ET | 900 | 20.76 |
| 11:15 ET | 400 | 20.695 |
| 11:18 ET | 6061 | 20.65 |
| 11:20 ET | 8755 | 20.68 |
| 11:22 ET | 7596 | 20.485 |
| 11:24 ET | 2650 | 20.32 |
| 11:26 ET | 19651 | 20.16 |
| 11:27 ET | 3414 | 20.32 |
| 11:29 ET | 1100 | 20.19 |
| 11:31 ET | 1394 | 20.295 |
| 11:33 ET | 5936 | 20.37 |
| 11:36 ET | 3091 | 20.49 |
| 11:38 ET | 300 | 20.45 |
| 11:40 ET | 780 | 20.62 |
| 11:42 ET | 1513 | 20.495 |
| 11:44 ET | 100 | 20.515 |
| 11:45 ET | 200 | 20.51 |
| 11:47 ET | 2165 | 20.4401 |
| 11:49 ET | 2208 | 20.41 |
| 11:51 ET | 100 | 20.41 |
| 11:54 ET | 4600 | 20.56 |
| 11:58 ET | 1850 | 20.59 |
| 12:00 ET | 200 | 20.62 |
| 12:02 ET | 1739 | 20.58 |
| 12:03 ET | 629 | 20.57 |
| 12:12 ET | 903 | 20.47 |
| 12:14 ET | 1657 | 20.58 |
| 12:16 ET | 4101 | 20.68 |
| 12:18 ET | 600 | 20.69 |
| 12:20 ET | 1400 | 20.665 |
| 12:21 ET | 20072 | 20.5 |
| 12:23 ET | 1100 | 20.4788 |
| 12:25 ET | 1506 | 20.39 |
| 12:27 ET | 200 | 20.41 |
| 12:30 ET | 1985 | 20.475 |
| 12:32 ET | 327 | 20.48 |
| 12:34 ET | 1127 | 20.47 |
| 12:36 ET | 202 | 20.44 |
| 12:38 ET | 500 | 20.46 |
| 12:39 ET | 300 | 20.41 |
| 12:41 ET | 200 | 20.36 |
| 12:45 ET | 100 | 20.36 |
| 12:48 ET | 900 | 20.42 |
| 12:54 ET | 100 | 20.42 |
| 12:56 ET | 2460 | 20.43 |
| 12:57 ET | 100 | 20.43 |
| 12:59 ET | 200 | 20.4 |
| 01:01 ET | 302 | 20.36 |
| 01:03 ET | 765 | 20.349 |
| 01:06 ET | 511 | 20.38 |
| 01:08 ET | 427 | 20.4 |
| 01:14 ET | 1300 | 20.46 |
| 01:15 ET | 1626 | 20.5 |
| 01:17 ET | 200 | 20.57 |
| 01:19 ET | 300 | 20.56 |
| 01:21 ET | 200 | 20.54 |
| 01:24 ET | 403 | 20.55 |
| 01:26 ET | 655 | 20.55 |
| 01:28 ET | 427 | 20.55 |
| 01:30 ET | 1148 | 20.52 |
| 01:33 ET | 3671 | 20.47 |
| 01:35 ET | 1016 | 20.47 |
| 01:37 ET | 3377 | 20.37 |
| 01:42 ET | 500 | 20.37 |
| 01:44 ET | 211 | 20.37 |
| 01:46 ET | 1700 | 20.43 |
| 01:48 ET | 1042 | 20.385 |
| 01:50 ET | 1413 | 20.29 |
| 01:51 ET | 100 | 20.29 |
| 01:53 ET | 6006 | 20.32 |
| 01:55 ET | 400 | 20.32 |
| 01:57 ET | 300 | 20.3 |
| 02:00 ET | 600 | 20.34 |
| 02:02 ET | 1259 | 20.38 |
| 02:04 ET | 1225 | 20.46 |
| 02:06 ET | 766 | 20.525 |
| 02:08 ET | 600 | 20.5125 |
| 02:11 ET | 126672 | 20.595 |
| 02:13 ET | 400 | 20.62 |
| 02:15 ET | 1272 | 20.69 |
| 02:18 ET | 327 | 20.77 |
| 02:20 ET | 200 | 20.74 |
| 02:22 ET | 1197 | 20.76 |
| 02:24 ET | 427 | 20.79 |
| 02:26 ET | 622 | 20.75 |
| 02:27 ET | 2083 | 20.64 |
| 02:29 ET | 600 | 20.7 |
| 02:31 ET | 100 | 20.64 |
| 02:33 ET | 1100 | 20.68 |
| 02:36 ET | 700 | 20.7 |
| 02:38 ET | 227 | 20.72 |
| 02:40 ET | 200 | 20.69 |
| 02:42 ET | 4261 | 20.775 |
| 02:44 ET | 600 | 20.8 |
| 02:45 ET | 600 | 20.765 |
| 02:47 ET | 1200 | 20.74 |
| 02:49 ET | 673 | 20.79 |
| 02:51 ET | 400 | 20.8 |
| 02:54 ET | 1001 | 20.73 |
| 02:56 ET | 889 | 20.68 |
| 02:58 ET | 1933 | 20.73 |
| 03:02 ET | 1400 | 20.735 |
| 03:03 ET | 200 | 20.72 |
| 03:05 ET | 1707 | 20.765 |
| 03:07 ET | 200 | 20.8 |
| 03:09 ET | 446 | 20.78 |
| 03:12 ET | 2013 | 20.82 |
| 03:16 ET | 800 | 20.8 |
| 03:18 ET | 1500 | 20.79 |
| 03:20 ET | 100 | 20.785 |
| 03:21 ET | 1109 | 20.7355 |
| 03:23 ET | 1205 | 20.745 |
| 03:25 ET | 100 | 20.72 |
| 03:27 ET | 3975 | 20.69 |
| 03:30 ET | 1929 | 20.71 |
| 03:32 ET | 127 | 20.71 |
| 03:34 ET | 800 | 20.735 |
| 03:36 ET | 1100 | 20.785 |
| 03:38 ET | 800 | 20.74 |
| 03:39 ET | 2127 | 20.71 |
| 03:41 ET | 3499 | 20.77 |
| 03:43 ET | 3044 | 20.76 |
| 03:45 ET | 7253 | 20.785 |
| 03:48 ET | 1400 | 20.845 |
| 03:50 ET | 4820 | 20.825 |
| 03:52 ET | 3312 | 20.86 |
| 03:54 ET | 2026 | 20.87 |
| 03:56 ET | 8063 | 20.92 |
| 03:57 ET | 5337 | 20.97 |
| 03:59 ET | 21764 | 20.91 |
Jun 27, 2024
DJ Nurix Therapeutics Is Maintained at Outperform by RBC Capital, from 10:40AM ET on Thursday Jun 27, 2024 by Dow Jones
10:40AM ET on Thursday Jun 27, 2024 by Dow Jones
Jun 18, 2024
DJ Nurix Therapeutics Is Maintained at Buy by HC Wainwright & Co., from 6:20AM ET on Tuesday Jun 18, 2024 by Dow Jones
6:20AM ET on Tuesday Jun 18, 2024 by Dow Jones
Jun 17, 2024
DJ Nurix Therapeutics Is Maintained at Overweight by JP Morgan, from 10:19AM ET on Monday Jun 17, 2024 by Dow Jones
10:19AM ET on Monday Jun 17, 2024 by Dow JonesDJ Nurix Therapeutics Shares Rise on Positive Leukemia Drug Results, from 6:23AM ET on Monday Jun 17, 2024 by Dow Jones
6:23AM ET on Monday Jun 17, 2024 by Dow JonesDJ Nurix Therapeutics Price Target Maintained With a $31.00/Share by Needham, from 5:59AM ET on Monday Jun 17, 2024 by Dow Jones
5:59AM ET on Monday Jun 17, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Nurix Therapeutics Inc | 1.2B | -7.9x | --- |
Vir Biotechnology Inc | 1.2B | -2.3x | --- |
Immatics NV | 1.2B | -11.5x | --- |
Prothena Corporation PLC | 1.1B | -6.3x | --- |
Arcutis Biotherapeutics Inc | 1.1B | -3.3x | --- |
Silence Therapeutics PLC | 874.4M | -16.7x | --- |
Company Information
Nurix Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecules and antibody therapies based on the modulation of cellular protein levels as a treatment approach for cancer, inflammatory conditions and other diseases. It DELigase is an integrated discovery platform, to identify and advance drug candidates targeting E3 ligases. Its drug candidates include NX-2127, NX-5948 and NX-1607. NX-2127 is an orally bioavailable Brutons tyrosine kinase (BTK) degrader that also degrades cereblon neosubstrates IKZF1 (Ikaros) and IKZF3 (Aiolos) for the treatment of relapsed or refractory B-cell malignancies. NX-5948 is an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and potentially autoimmune diseases. NX-1607 is an oral clinical-stage small molecule drug candidate that inhibits Casitas B-lineage lymphoma proto-oncogene-B (CBL-B).
Contact Information
- Headquarters
- 1700 Owens St Ste 205SAN FRANCISCO, CA, United States 94158-0006
- Phone
- 415-660-5320
- Fax
- 415-525-4200
Executives
- Independent Chairman of the Board
- Julia Gregory
- President, Chief Executive Officer, Director
- Arthur Sands
- Chief Financial Officer
- Hans van Houte
- Chief Technical Officer
- Pasit Phiasivongsa
- Chief Scientific Officer
- Gwenn Hansen
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.2B |
|---|---|
Revenue (TTM) | $80.9M |
Shares Outstanding | 59.3M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 2.22 |
EPS | $-2.65 |
Book Value | $4.12 |
P/E Ratio | -7.9x |
Price/Sales (TTM) | 15.3 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -194.51% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
